Revised criteria for Alzheimer's disease: what are the lessons for clinicians?

被引：19
作者：
Frisoni, Giovanni B. [1 ]
Hampel, Harald [2 ]
O'Brien, John T. [3 ]
Ritchie, Karen [4 ,5 ]
Winblad, Bengt [6 ]
机构：
[1] Fatebenefratelli, Inst Recovero & Cura Carattere Sci, I-25125 Brescia, Italy
[2] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany
[3] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] INSERM, U1061, Montpellier, France
[5] Univ London Imperial Coll Sci Technol & Med, London, England
[6] Karolinska Inst, Alzheimer Dis Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden
来源：
LANCET NEUROLOGY | 2011年 / 10卷 / 07期
关键词：
ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RECOMMENDATIONS; BIOMARKERS;
D O I：
10.1016/S1474-4422(11)70126-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：598 / 601
页数：4
相关论文
共 50 条
  • [31] Neuropsychological Profiles and Trajectories in Preclinical Alzheimer's Disease
    Ho, Jean K.
    Nation, Daniel A.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2018, 24 (07) : 693 - 702
  • [32] Progress in Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    JOURNAL OF NEUROLOGY, 2012, 259 (02) : 201 - 211
  • [33] What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis
    Ketchum, Fred B.
    Erickson, Claire M.
    Chin, Nathaniel A.
    Gleason, Carey E.
    Lambrou, Nickolas H.
    Benton, Susan Flowers
    Clark, Lindsay R.
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 87 (03) : 1167 - 1179
  • [34] Clinical utility and applicability of biomarker-based diagnostic criteria for Alzheimer's disease: a BeDeCo survey
    Bier, Jean-Christophe
    Verschraegen, Jurn
    Vandenberghe, Rik
    Guillaume, Benedicte
    Picard, Gaetane
    Otte, Georges
    Mormont, Eric
    Gilles, Christian
    Segers, Kurt
    Sieben, Anne
    Thiery, Evert
    Ventura, Manfredi
    De Deyn, Peter
    Deryck, Olivier
    Versijpt, Jan
    Salmon, Eric
    Engelborghs, Sebastiaan
    Ivanoiu, Adrian
    ACTA NEUROLOGICA BELGICA, 2015, 115 (04) : 547 - 555
  • [35] Heterogeneity of Alzheimer's disease
    Balazs Nora
    Kovacs Tibor
    ORVOSI HETILAP, 2021, 162 (25) : 970 - 977
  • [36] Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research
    Bieger, Andrei
    Brum, Wagner S.
    Borelli, Wyllians V.
    Therriault, Joseph
    De Bastiani, Marco A.
    Moreira, Amanda G.
    Benedet, Andrea L.
    Ferrari-Souza, Joao Pedro
    Da Costa, Jaderson C.
    Souza, Diogo O.
    Castilhos, Raphael M.
    Schuh, Artur Francisco Schumacher
    Chaves, Marcia L. Fagundes
    Schoell, Michael
    Zetterberg, Henrik
    Blennow, Kaj
    Pascoal, Tharick A.
    Gauthier, Serge
    Rosa-Neto, Pedro
    Schilling, Lucas P.
    Zimmer, Eduardo R.
    NEUROLOGY, 2024, 103 (05)
  • [37] Preclinical Disease or Risk Factor? Alzheimer's Disease as a Case Study of Changing Conceptualizations of Disease
    Schermer, Maartje H. N.
    JOURNAL OF MEDICINE AND PHILOSOPHY, 2023, 48 (04): : 322 - 334
  • [38] Decreased salivary lactoferrin levels are specific to Alzheimer's disease
    Gonzalez-Sanchez, Marta
    Bartolome, Fernando
    Antequera, Desiree
    Puertas-Martin, Veronica
    Gonzalez, Pilar
    Gomez-Grande, Adolfo
    Llamas-Velasco, Sara
    Herrero-San Martin, Alejandro
    Perez-Martinez, David
    Villarejo-Galende, Alberto
    Atienza, Mercedes
    Palomar-Bonet, Miriam
    Luis Cantero, Jose
    Perry, George
    Orive, Gorka
    Ibanez, Borja
    Bueno, Hector
    Fuster, Valentin
    Carro, Eva
    EBIOMEDICINE, 2020, 57 : 102834
  • [39] Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer's Disease
    Agnello, Luisa
    Lo Sasso, Bruna
    Vidali, Matteo
    Scazzone, Concetta
    Piccoli, Tommaso
    Gambino, Caterina Maria
    Bivona, Giulia
    Giglio, Rosaria Vincenza
    Ciaccio, Anna Maria
    La Bella, Vincenzo
    Ciaccio, Marcello
    DIAGNOSTICS, 2021, 11 (12)
  • [40] Clinical use of biomarkers in the era of Alzheimer's disease treatments
    Vandevrede, Lawren
    Schindler, Suzanne E.
    ALZHEIMERS & DEMENTIA, 2025, 21 (01)
12345